MET and non-small cell lung carcinoma: It has been shown in non-small cell lung cancer (NSCLC) that a receptor tyrosine kinase (RTK), MET, is a potential miR-203- targeted gene, and an inverse correlation between miR-203 and MET expression exists [21].